UNSPSC 51241223: Calcipotriene or calcipotriol

This classification denotes an anti-psoriatic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 143NQ3779B. European Medicines Agency schedules Calcipotriol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06046MIG. Calcipotriene generally arises in the molecular formula C27H40O3. The term CALCIPOTRIENE is an International Non-Proprietary Name or INN. Calcipotriene or calcipotriol bears US NLM identifiers UMLS ID C0065767 and NCI Concept Code C28900.

SMILES: CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C.

UNSPSC 51241223 Calcipotriene or calcipotriol is a Commodity code that shows no relevant recent state and local procurement activity. The two posted opportunities in the source — one for liquid aluminum sulfate from the City of Austin Water Department (IFB posted July 27, 2026, due August 25, 2026) and one for medical aid supplies from the City of Tampa Fire Rescue Department (ITB posted April 24, 2026) — are unrelated to calcipotriene or calcipotriol, a pharmaceutical agent used topically to treat psoriasis and other skin conditions. The misalignment between the code's pharmaceutical scope and the chemical-treatment and first-aid-supply work actually being solicited suggests either a tagging error or dormancy under this code in state and local procurement.

Without recent opportunities aligned to calcipotriene procurement, geographic concentration and issuing-body patterns cannot be established from the source. Any state or local procurement of this agent may occur through existing pharmaceutical vendor contracts, state health-department formulary agreements, or cooperative purchasing vehicles rather than standalone bids or RFPs. Monitor this code for future activity, but current signals do not support near-term pursuit.